Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NanoString Technologies Inc (NASDAQ:NSTG)

18.82
Delayed Data
As of 12:51pm ET
 -0.21 / -1.10%
Today’s Change
11.70
Today|||52-Week Range
23.45
-15.61%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$399.7M

Company Description

NanoString Technologies, Inc. engages in the provision of life science tools for translational research and molecular diagnostic products under the nCounter brand. It develops, manufactures, and commercializes instruments, consumables, and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.

Contact Information

NanoString Technologies, Inc.
530 Fairview Avenue North
Seattle Washington 98109
P:(206) 378-6266
Investor Relations:
(206) 602-1768

Employees

Shareholders

Other institutional53.32%
Individual stakeholders31.15%
Mutual fund holders17.13%

Top Executives

Robert Bradley GrayPresident, Chief Executive Officer & Director
Wayne D. BurnsSenior Vice President-Operations & Administration
James Algot JohnsonCFO & Principal Accounting Officer
Alessandra CesanoChief Medical Officer
Kathryn Surace-SmithSecretary, Vice President & General Counsel